Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue – PRN Methylphenidate
Condition(s):FatigueLast Updated:January 4, 2022Completed
Hide Studies Not Open or Pending
Condition(s):FatigueLast Updated:January 4, 2022Completed
Condition(s):Multiple SclerosisLast Updated:April 5, 2018Completed
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:November 1, 2018Withdrawn
Condition(s):Visual Field TestsLast Updated:April 11, 2018Completed
Condition(s):Substance-Related DisordersLast Updated:July 20, 2018Withdrawn
Condition(s):Dementia; Accidental Falls; ApathyLast Updated:July 24, 2018Terminated
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:May 13, 2016Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:May 3, 2019Unknown status
Condition(s):Apathy; Alzheimer’s DiseaseLast Updated:June 13, 2023Completed
Condition(s):Epilepsy; Cognitive Deficits; Attention DeficitsLast Updated:May 30, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.